https://orcid.org/0000-0001-5986-6528
Arantxa obtained a Master degree in Biochemistry in 1999, followed by a PhD degree at the University of Navarra in 2003, where she studied the involvement of myocardial apoptosis in the development of heart failure. She completed her postdoctoral training at the New York Medical College (New York, USA) and the Brigham and Women's Hospital (Boston, USA). In 2005 she was granted the Norman R. Alpert Award from the European Society on Cardiology and the American Heart Association. Currently, Dr González-Miqueo is Director of the Program of Cardiovascular Disease (Centre for Applied Medical Research/CIMA-Universidad de Navarra), Associate Professor of the School of Medicine (University of Navarra), and a group leader at the Spanish Cardiovascular Research Network (CIBERCV). She was appointed as a Fellow of the Spanish Royal Academy of Science in 2023.
Arantxa in an Expert on the mechanisms involved in myocardial remodelling, especially the extracellular matrix, which plays a major role in the evolution of heart failure, as well as in the search for non-invasive circulating biomarkers of remodelling. She has led over 20 competitive research projects, including National (Spanish) and European Commission-funded projects. Her current research focus is to identify clinically useful non-invasive circulating biomarkers for improved diagnosis, risk stratification and personalized management in heart failure; and to delve into cardiac fibrosis mechanisms to identify novel therapeutic targets.





